|
|
||||||||
Original Research |
1 Department of Radiology, Erasmus University Medical Center, Dr. Molewaterplein
40, Rotterdam, The Netherlands, 3015 GD.
2 Department of Neurology, Erasmus University Medical Center, Rotterdam, The
Netherlands.
Received January 28, 2005;
accepted after revision April 27, 2005.
Address correspondence to A. van der Lugt
(a.vanderlugt{at}erasmusmc.nl).
Abstract
|
|
|---|
SUBJECTS AND METHODS. Eighty consecutive patients (51 men; mean age, 62 years; age range, 28-89 years) underwent scanning in the caudocranial direction (group 1; n = 40) or the craniocaudal direction (group 2; n = 40). All patients received 80 mL of contrast material followed by a 40-mL saline chaser bolus, both administered IV at 4 mL/sec. Bolus tracking was used. Attenuation inside the arterial lumen was measured at intervals of 1 sec throughout the data set. Attenuation in the superior vena cava (SVC) was measured. Contrast material-related perivenous artifacts were graded on a scale of 0-3 (none to extensive).
RESULTS. Attenuation in the ascending aorta, carotid bifurcation, and intracranial arteries was slightly lower in group 2 versus group 1 (231 ± 64 H, 348 ± 52 H, and 258 ± 48 H vs 282 ± 43 H, 381 ± 73 H, and 291 ± 77 H, respectively; p < 0.05). Maximum and mean arterial attenuations were slightly lower in group 2 versus group 1 (369 ± 58 H and 303 ± 48 H vs 401 ± 71 H and 334 ± 58 H; p < 0.05). Attenuation in the SVC was much lower in group 2 versus group 1 (169 ± 39 H vs 783 ± 330 H; p < 0.001). Mean streak artifact score was much lower in group 2 versus group 1 (1.3 ± 0.9 vs 2.5 ± 0.6; p < 0.001).
CONCLUSION. Use of a craniocaudal scan direction results in slightly lower attenuation of the carotid artery and much lower attenuation of the SVC. Streak artifacts are significantly reduced. This technique allows better evaluation of the ascending aorta and supraaortic arteries.
Keywords: arteries cardiovascular disease cardiovascular imaging CT angiography CT technique perivenous artifacts
|
|
|---|
With the introduction of MDCT, particularly 16-MDCT scanners, CT angiography (CTA) has become an attractive diagnostic method in the care of patients with cerebrovascular symptoms [4]. With bolus tracking, CTA scanning can be optimally synchronized with the passage of contrast material in the arteries [5]. The CTA scanning usually starts before the injection of contrast material ends. With this method, the presence of undiluted contrast material in the subclavian vein, brachiocephalic vein, and superior vena cava (SVC) produces artifacts that project over the ascending aorta and the origin of the supraaortic arteries [6, 7]. Such artifacts can obscure adjacent structures and thus hide or suggest stenosis or occlusion of the proximal supraaortic arteries (Figs. 1A, 1B, 1C and 1D). Addition of a chaser bolus to the main contrast bolus may reduce the frequency of these artifacts by clearing the veins of contrast material. However, the timing of the CTA scan is not altered by the addition of a chaser bolus, and artifacts do occur. Use of a craniocaudal scan direction, opposite to the direction of blood flow, may reduce the number of artifacts caused by delayed scanning of the apex of the thorax (Figs. 2A, 2B, 2C and 2D).
|
|
|
|
|
|
|
|
|
|
|---|
Each patient was allocated to one of two groups with different scan protocols. The first 40 patients (group 1) underwent scanning in the caudal to cranial direction, the second 40 patients (group 2) underwent scanning in the cranial to caudal direction. Age, sex, and body weight were recorded for each patient.
Scan Protocol
The patients underwent CTA of the carotid artery with a 16-MDCT scanner
(Sensation 16, Siemens Medical Solutions). Patients were positioned supine on
the CT table with the arms along the chest. A lateral scout view including the
thorax, neck, and skull was acquired. The CTA scan range reached from the
ascending aorta to the intracranial blood vessels (2 cm above the sella
turcica). Scan parameters were as follows: number of detectors, 16; individual
detector width, 0.75 mm; table feed per rotation, 12 mm (pitch of 1); gantry
rotation time, 0.5 sec; 120 kV; 180 mAs; and scanning time, 10-14 sec,
depending on patient's size and anatomic features. The entire examination took
approximately 15 min.
Contrast material (iodixanol 320 mg I/mL [Visipaque, Amersham Health]) was injected with a double-head power injector (Stellant, Medrad) through an 18- to 20-gauge IV cannula (depending on the size of the vein) in an antecubital vein. The right antecubital vein was preferentially used because it provides the shortest path for contrast material through the venous system and therefore the least dilution. When venous access could not be achieved on the right side, the left antecubital vein was used. The saline chaser bolus was injected through the second head of the power injector immediately after injection of contrast material was completed. All patients received 80 mL of contrast material and a 40-mL saline chaser bolus, both at an injection rate of 4 mL/sec.
Synchronization between the passage of contrast material and data
acquisition was achieved with real-time bolus tracking. The arrival of the
injected contrast material was monitored in real time with a series of dynamic
axial low-dose monitoring scans (120 kV, 20-40 mAs) at the level of the
ascending aorta at intervals of 1 sec. The monitoring sequence started 5 sec
after initiation of administration of contrast material. The CTA scan was
triggered automatically by means of a threshold measured in a region of
interest (ROI) set in the ascending aorta. The size of the ROI in the
ascending aorta for the bolus triggering was adjusted to the size and
composition of the ascending aorta but was always greater than 5 mm in
diameter. The trigger threshold was set at an increase in attenuation of 75 H
above baseline attenuation (
150 H in absolute H value). When the
threshold was reached, the table was moved to the start position while the
patient was instructed not to swallow. Breath-hold instructions were not given
to the patient. CTA data acquisition was started automatically 4 sec
(caudocranial scan direction) or 6 sec (craniocaudal scan direction) after the
trigger threshold was reached. All bolus timing procedures and CTA scans were
successfully completed. No significant adverse reactions to contrast material
or other side effects occurred.
Data Collection and Analysis
Images were reconstructed with an effective slice width of 1 mm,
reconstruction interval of 0.6 mm, field of view of 100 mm, and convolution
kernel B30f (medium smooth). The images were transferred to a stand-alone
workstation and evaluated with dedicated analysis software (Leonardo, Siemens
Medical Solutions).
For each patient, site of injection and scan delay (in seconds) were recorded. Axial images were used for the attenuation measurements. On each 40th slice (1-sec interval), beginning with the most caudal slice, an ROI was drawn throughout the data sets in two regions: the ascending aorta to the right ICA and the ascending aorta to the left ICA. Measurements were recorded at the following locations: ascending aorta, aortic arch, proximal CCA (first two measurements in the CCA), distal CCA, proximal ICA (first two measurements in the ICA), distal ICA, carotid siphon, and intracranial part of the ICA. Measurements in the brachiocephalic trunk were considered measurements in the CCA.
Two observers measured and recorded all data. Attenuation was measured by drawing a circular ROI in the center of the vessel lumen. The ROI was drawn as large as the anatomic configuration of the lumen allowed in the axial slice. The mean value of the measurements on the left and the right side at each time point was calculated. Time-attenuation curves were generated for each patient, and mean, minimum, and maximum attenuations were assessed. Because attenuation greater than 200 H was considered optimal, the number of measurements less than 200 H was counted. The analysis resulted in one to three measurements per location depending on the size of the patient. For analysis of attenuation, the measurements obtained in these locations were averaged.
Contrast material-related perivenous artifacts were graded on a four-point scale adjusted from Rubin et al. [6] and Vogel et al. [8] (Figs. 3A, 3B, 3C and 3D). A score of 0 indicated no streak artifacts and clear anatomic detail; 1, minimal streak artifacts without notable obscuration of adjacent arteries; 2, moderate streak artifacts partially obscuring adjacent arteries; and 3, extensive streak artifacts completely obscuring adjacent arteries. The artifact score was assessed by two observers blinded to scan protocol. In case of a lack of congruence, consensus was reached. Attenuation in the SVC was measured in the most caudal slice. Reflux of contrast material in the veins of the neck was measured in centimeters on a coronal maximum-intensity-projection image.
|
|
|
|
|
|
|---|
|
Caudocranial Scan Direction
Mean arterial attenuation for the caudocranial scan direction was 334
± 58 H (Table 2). The
minimum and maximum arterial attenuations were 255 ± 50 H and 401
± 71 H. Fifteen measurements in five of the 40 patients (513
measurements) had an attenuation less than 200 H. These measurements were
obtained in the ascending aorta (n = 2), aortic arch (n =2),
CCA (n = 3), ICA (n = 1), carotid siphon (n = 2),
and intracranial arteries (n =5).
|
Craniocaudal Scan Direction
The mean arterial attenuation per patient was 303 ± 48 H
(Table 2). The minimum and
maximum arterial attenuations per patient were 212 ± 49 H and 369
± 58 H. Sixty-nine of the measurements in 16 of the 40 patients (493
measurements) had an attenuation less than 200 H. These measurements were
obtained in the ascending aorta (n = 23), aortic arch (n =
12), CCA (n =15), ICA (n = 8), carotid siphon (n =
5), and intracranial arteries (n =6).
Comparison of Attenuation Curves
Group 2, in whom the craniocaudal scan direction was used, had lower mean,
maximum, and minimum attenuations (p < 0.05) than group 1, in whom
the caudocranial scan direction was used (Tables
2 and
3, Figs.
4 and
5). After adjustment for age
and weight, no significant difference was found in mean (p = 0.07) or
maximum (p = 0.26) attenuation. Minimum attenuation remained
significantly different (p < 0.01). In both patient groups,
maximum attenuation was reached in the proximal ICA.
|
|
|
The craniocaudal scan direction resulted in significantly lower attenuation in all locations (p < 0.05), except for the proximal CCA (p = 0.39). After adjustment for age and weight, no significant difference was found for the aortic arch (p = 0.07), proximal CCA (p = 0.87), distal CCA (p = 0.17), proximal ICA (p = 0.21), or distal ICA (p = 0.16). Attenuation in the ascending aorta, carotid siphon, and intracranial arteries remained significantly different (p <0.05).
Comparison of Artifacts
Attenuation in the SVC was much higher in group 1 (caudocranial) than in
group 2 (craniocaudal): 782 ± 330 H (range, 183-2,083 H) and 169
± 39 H (range, 102-288 H) (p < 0.001)
(Table 4). The mean artifact
scores were 2.5 ± 0.6 and 1.3 ± 0.9 for groups 1 and 2,
respectively (p < 0.001). All but one of the patients in group 1
had an artifact score of 2 or more. Extensive streak artifacts completely
obscuring adjacent arteries (score of 3) were seen in 21 (53%) of the patients
in group 1 and in three (8%) of the patients in group 2. Reflux of contrast
material in the neck veins measured 2.9 ± 2.4 cm (range, 0-14.4 cm) and
1.2 ± 1.5 cm (range, 0-5.1 cm) in groups 1 and 2 (p <
0.001). Reflux of contrast material in the neck veins measuring more than 2 cm
was seen in group 1 in 24 (60%) of the patients and in group 2 in 11 (28%) of
the patients (p < 0.001).
|
Comparison of Left and Right Injection Sides
In group 2 (craniocaudal scan direction) there was more reflux and a higher
artifact score with left-sided injection than with right-sided injection,
although the difference was significant only for reflux (p < 0.01)
and almost significant for artifact score (p = 0.08)
(Table 5). Attenuation of the
SVC was higher in patients who received a right-sided injection, although the
difference was not significant (p = 0.19).
|
Relationships Among Artifact Parameters
There was a significant relation between attenuation of the SVC and
artifact score (Spearman's r = 0.62, p < 0.001) (Figs.
6A,
6B). A clear cutoff point was
seen at an attenuation of the SVC of ± 200 H. Above this level,
artifacts interfered with evaluation of the arteries. There was also a
significant relation between reflux in the neck veins and artifact score
(Spearman's r = 0.52, p <0.001).
|
|
|
|
|---|
Rubin et al. [6], who performed helical CT with an injection duration of 40 sec and a scan delay of 25 sec, found that 3:1 dilution of contrast material resulted in diminished perivenous artifacts. To keep the same total injected iodine dose with a 3:1 dilution, the total injected volume and the injection rate have to be increased four times. In CTA, however, dilution of contrast material is not an option because the already high injection rate should be increased to more than 10 mL/sec in maintaining the injected iodine dose.
Haage et al. [5] tested the effect of the addition of a chaser bolus to the main contrast material bolus and subsequent reduction of contrast material. They found a reduction in perivenous artifacts. This result can be explained by the reduction in total iodine concentration and shorter contrast material injection time rather than use of a chaser bolus after the main bolus.
In theory, to prevent perivenous artifacts, a chaser bolus is useful in CTA only when the scan starts after injection of contrast material ends. In our study, the optimal scan delay was within the injection period of 20 sec in most of the patients. Although use of a chaser bolus in CTA of the supraaortic arteries leads to optimal use of contrast material [4], it does not decrease perivenous artifacts.
To synchronize data acquisition relative to optimal arterial enhancement, the scan direction in CTA usually is in the direction of blood flow [10]. With 16-MDCT, scanning time in CTA of the supraaortic arteries has decreased to less than 15 sec. This change may allow reversal of the scan direction without a compromise in vascular attenuation. In addition, perivenous artifacts may decrease because of the delay in scanning of the apex of the thorax when a craniocaudal scan direction is used.
Our study showed that a craniocaudal scan direction resulted in slightly lower attenuation of the carotid artery, although attenuation remained high enough for good evaluation, in comparison with a caudocranial scan direction. With both scan directions, peak attenuation was at the level of the proximal ICA, which is the most relevant site. After adjustment for age and weight, no significant difference in mean or maximum attenuation was found for the two scan directions. Minimum attenuation, however, was significantly lower for the craniocaudal scan direction. The explanation is that the scan direction is the opposite of the direction of blood flow, and to have maximal enhancement at the halfway point (the level of the proximal ICA), the scan is at the cranial level a little too early and at the caudal part a little too late for optimal enhancement. Therefore, attenuation at the beginning and at the end of the craniocaudal scan, and thus minimum attenuation, is lower than for a caudocranial scan. This factor is also reflected in the significantly lower attenuation, after adjustment for age and weight, at the ascending aorta, carotid siphon, and intracranial arteries and the lack of difference in attenuation at locations in between.
We found that a craniocaudal scan direction resulted in much lower attenuation of the SVC, which resulted in fewer perivenous artifacts. By the time the craniocaudal scan reaches the apex of the thorax, injection of contrast material has ended, and contrast material has been flushed from the veins by the chaser bolus.
There was a tendency to increased artifacts with left-sided injection compared with right-sided injection, although this difference was not significant (p = 0.08 for the craniocaudal scan direction). The explanation is that venous return in the left subclavian vein, because of its transverse course into the SVC, may be more likely to be affected by changes in intrathoracic pressure and to be compressed by normal structures, such as the aorta. These effects can cause more pooling of contrast material in the subclavian vein and more reflux in the neck veins with left-sided injection than occurs with right-sided injection [11]. We found more reflux in patients in the craniocaudal scan direction group who received a left-sided injection (p < 0.01) and a significant relation between reflux and artifacts (p < 0.01).
A limitation of our study was that the groups were not randomly allocated. Baseline characteristics, however, were not significantly different. Another limitation was that our results probably will not apply when bolus triggering is not used to optimize the timing of data acquisition. The timing for a craniocaudal scan direction has to be more precise than for a caudocranial scan direction. Without bolus triggering, data acquisition may be too early for good arterial attenuation in the intracranial arteries and too late for good attenuation in the aorta.
In conclusion, we advocate the use of a craniocaudal scan direction in 16-MDCT angiography of the supraaortic arteries. Right-sided injection is preferred over left-sided injection. This protocol results in good arterial attenuation, low attenuation of the SVC, and few perivenous artifacts and facilitates evaluation of the ascending aorta and supraaortic arteries.
|
|
|---|
This article has been cited by other articles:
![]() |
T. T. de Weert, S. Cretier, H. C. Groen, P. Homburg, H. Cakir, J. J. Wentzel, D. W.J. Dippel, and A. van der Lugt Atherosclerotic Plaque Surface Morphology in the Carotid Bifurcation Assessed With Multidetector Computed Tomography Angiography Stroke, April 1, 2009; 40(4): 1334 - 1340. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |